Aarti Pharmalabs Limited
NSE: AARTIPHARM BSE: AARTIPHARM
NSE
753.90
16.90 (2.29%)
Prev Close
737
Open Price
733
Volume
548,769
Today Low / High
732.25 / 767.8
52 WK Low / High
487.85 / 837.25
Range
716 - 792
BSE
754.25
17.30 (2.35%)
Prev Close
736.95
Open Price
717.3
Volume
16,178
Today Low / High
717.3 / 767.65
52 WK Low / High
486.3 / 837
Range
717 - 792
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 753.9 (target range: 716 - 792), reflecting a change of 16.9 (2.29308%). On the BSE, it is listed at 754.25 (target range: 717 - 792), showing a change of 17.3 (2.34751%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
24 Apr
733.00
2.85%
23 Apr
715.90
2.95%
22 Apr
710.00
0.27%
21 Apr
733.60
-2.83%
17 Apr
716.00
2.46%
16 Apr
719.80
-0.35%
15 Apr
703.40
1.43%
11 Apr
667.35
1.81%
09 Apr
633.25
-1.40%
08 Apr
670.00
-4.05%
07 Apr
585.00
11.07%
04 Apr
804.00
-13.45%
03 Apr
768.00
5.08%
02 Apr
756.95
-0.55%
01 Apr
745.10
1.13%
28 Mar
749.25
0.00%
27 Mar
733.00
1.77%
Aarti Pharmalabs Limited Graph
Aarti Pharmalabs Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aarti Pharmalabs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 753.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 754.25 | 761.79 | 685.61 - 837.97 |
| 769.34 | 615.47 - 923.20 | ||
| 776.88 | 543.81 - 1,009.94 | ||
| Bearish Scenario | 754.25 | 746.71 | 672.04 - 821.38 |
| 739.17 | 591.33 - 887.00 | ||
| 731.62 | 512.14 - 951.11 |
Overview of Aarti Pharmalabs Limited
ISIN
INE0LRU01027
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
924,090
Market Cap
68,329,440,018
Last Dividend
3.5
Official Website
IPO Date
2023-01-30
DCF Diff
-138.48
DCF
857
Financial Ratios Every Investor Needs
Stock Dividend of AARTIPHARM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-02-14 | February 14, 25 | 2.5 | 2.5 | 2025-02-14 | 2025-03-07 | |
| 2024-07-31 | July 31, 24 | 1 | 1 | 2024-07-31 | 2024-09-02 | |
| 2024-02-16 | February 16, 24 | 2 | 2 | 2024-02-19 | 2024-03-08 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1,815.51 Cr | 1,424.71 Cr | 390.80 Cr | 0.2153 | 8.37 Cr | 12.39 Cr | 312.81 Cr | 216.90 Cr | 23.93 | 390.94 Cr | 0.1195 |
| 2023-03-31 | 1,945.23 Cr | 1,531.36 Cr | 413.87 Cr | 0.2128 | 13.96 Cr | 14.44 Cr | 279.51 Cr | 193.49 Cr | 21.35 | 344.37 Cr | 0.0995 |
| 2022-03-31 | 1,192.03 Cr | 879.70 Cr | 312.33 Cr | 0.2620 | 0.00 Cr | 1.51 Cr | 164.83 Cr | 122.25 Cr | 13.49 | 197.84 Cr | 0.1026 |
| 2021-03-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.18 | 0.00 Cr | 0.0000 |
| 2020-03-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | 0.00 Cr | 0.00 Cr | -0.02 Cr | -0.02 Cr | -0.75 | 0.00 Cr | 0.0000 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 23.63 Cr | 2,582.11 Cr | 825.07 Cr | 1,757.0400 Cr | 285.25 Cr | 261.62 Cr | 642.86 Cr | 1,105.45 Cr | 0.00 Cr | 0.00 Cr | 36.78 Cr | 694.3891 Cr |
| 2023-03-31 | 12.12 Cr | 2,244.02 Cr | 685.54 Cr | 1,558.4866 Cr | 215.31 Cr | 203.19 Cr | 602.04 Cr | 988.57 Cr | 0.00 Cr | 0.00 Cr | -6.03 Cr | 600.6234 Cr |
| 2022-03-31 | 83.27 Cr | 2,039.90 Cr | 653.42 Cr | 1,386.4778 Cr | 341.40 Cr | 258.13 Cr | 475.45 Cr | 945.31 Cr | 0.00 Cr | -1.00 Cr | 32.23 Cr | 580.6649 Cr |
| 2021-03-31 | 0.25 Cr | 0.25 Cr | 0.02 Cr | 0.2267 Cr | 0.02 Cr | -0.23 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0219 Cr |
| 2020-03-31 | 0.25 Cr | 0.25 Cr | 0.02 Cr | 0.2313 Cr | 0.02 Cr | -0.23 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 216.3546 Cr | -214.5644 Cr | 9.7235 Cr | 17.5695 Cr | 11.5137 Cr | 23.6349 Cr | -155.6042 Cr | 216.9020 Cr | 49.9934 Cr | -18.1252 Cr | -39.6600 Cr |
| 2023-03-31 | 250.1154 Cr | -157.8030 Cr | -163.4646 Cr | 130.4585 Cr | -71.1522 Cr | 12.1212 Cr | -119.6569 Cr | 260.7747 Cr | -124.2877 Cr | -18.1252 Cr | -126.6600 Cr |
| 2022-03-31 | -43.7038 Cr | -138.7389 Cr | 260.3834 Cr | -184.8558 Cr | 83.0234 Cr | 83.2734 Cr | -141.1520 Cr | 155.3804 Cr | 272.3422 Cr | 0.0000 Cr | -55.9920 Cr |
| 2021-03-31 | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.2500 Cr | 0.0000 Cr | -0.0046 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
| 2020-03-31 | -0.0187 Cr | 0.0000 Cr | 0.2687 Cr | -0.0187 Cr | 0.2500 Cr | 0.2500 Cr | 0.0000 Cr | -0.0187 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 537.78 Cr | 275.31 Cr | 262.47 Cr | 0.4881 | 105.57 Cr | 73.99 Cr | 8.16 | 133.64 Cr | 0.1376 |
| 2024-09-30 | 458.03 Cr | 294.19 Cr | 163.84 Cr | 0.3577 | 72.79 Cr | 54.62 Cr | 6.03 | 98.16 Cr | 0.1193 |
| 2024-06-30 | 555.49 Cr | 397.64 Cr | 157.85 Cr | 0.2842 | 76.29 Cr | 55.45 Cr | 6.12 | 98.68 Cr | 0.0998 |
| 2024-03-31 | 505.77 Cr | 309.64 Cr | 196.13 Cr | 0.3878 | 98.40 Cr | 65.25 Cr | 7.20 | 119.55 Cr | 0.1290 |
| 2023-12-31 | 448.69 Cr | 244.43 Cr | 204.26 Cr | 0.4552 | 76.91 Cr | 52.76 Cr | 5.82 | 97.06 Cr | 0.1176 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 40.81 Cr | 58.16 Cr | 99.51 Cr | 434.38 Cr | 719.80 Cr | 1,376.67 Cr | 1,228.35 Cr | 2,776.51 Cr | 919.79 Cr |
| 2024-06-30 | -94.32 Cr | 188.63 Cr | 94.32 Cr | 0.00 Cr | 0.00 Cr | 94.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 23.63 Cr | 70.40 Cr | 94.45 Cr | 519.34 Cr | 642.86 Cr | 1,345.64 Cr | 1,105.45 Cr | 2,582.11 Cr | 825.07 Cr |
| 2023-12-31 | -69.77 Cr | 139.54 Cr | 69.77 Cr | 0.00 Cr | 0.00 Cr | 69.77 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 24.53 Cr | 94.33 Cr | 118.86 Cr | 0.00 Cr | 602.55 Cr | 1,166.68 Cr | 1,032.95 Cr | 2,313.21 Cr | 655.69 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 55.45 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 65.25 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 52.76 Cr | 37.54 Cr | 0.00 Cr | 0.00 Cr | 37.54 Cr | 62.15 Cr | 24.61 Cr | 0.00 Cr | 37.54 Cr |
| 2023-09-30 | 51.80 Cr | 36.28 Cr | 0.00 Cr | 0.00 Cr | 36.28 Cr | 24.61 Cr | 0.00 Cr | 0.00 Cr | 36.28 Cr |
| 2023-06-30 | 47.09 Cr | 34.40 Cr | 0.00 Cr | 0.00 Cr | 47.28 Cr | 59.40 Cr | 12.12 Cr | 0.00 Cr | 34.40 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,803.90 | ₹4,328,061,192,000.00 | ₹2,100,537.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,215.50 | ₹1,650,019,896,835.00 | ₹2,081,003.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,325.10 | ₹1,125,363,469,500.00 | ₹233,320.00 |
| Mankind Pharma Limited | MANKIND | ₹2,599.20 | ₹1,072,374,089,184.00 | ₹377,773.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,200.50 | ₹1,000,152,180,510.00 | ₹4,818,144.00 |
| Lupin Limited | LUPIN | ₹2,104.10 | ₹960,658,479,623.00 | ₹1,580,050.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹880.25 | ₹885,733,957,500.00 | ₹1,164,194.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,257.80 | ₹730,532,755,600.00 | ₹1,338,274.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,201.20 | ₹621,881,478,000.00 | ₹138,164.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,420.90 | ₹400,960,929,200.00 | ₹1,391,085.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,445.70 | ₹366,779,872,800.00 | ₹175,209.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,790.40 | ₹348,554,444,800.00 | ₹239,346.00 |
| Laurus Labs Limited | LAURUSLABS | ₹645.50 | ₹348,087,811,500.00 | ₹7,230,008.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,204.80 | ₹306,699,912,000.00 | ₹269,079.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,609.10 | ₹250,500,214,702.00 | ₹175,168.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,465.20 | ₹238,064,230,800.00 | ₹1,148,314.00 |
| Piramal Enterprises Limited | PEL | ₹1,021.60 | ₹230,348,324,800.00 | ₹349,675.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,967.50 | ₹224,187,500,000.00 | ₹18,935.00 |
| Eris Lifesciences Limited | ERIS | ₹1,512.00 | ₹205,827,048,000.00 | ₹433,227.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹880.55 | ₹173,083,664,122.00 | ₹310,579.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,079.00 | ₹167,802,262,100.00 | ₹52,920.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹902.85 | ₹161,709,463,500.00 | ₹16,724,971.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹952.65 | ₹151,739,178,021.00 | ₹684,427.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,884.40 | ₹143,236,447,480.00 | ₹153,894.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹475.05 | ₹115,220,527,200.00 | ₹1,362,207.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,221.50 | ₹86,673,767,100.00 | ₹4,879.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹721.80 | ₹70,585,471,620.00 | ₹517,725.00 |
| FDC Limited | FDC | ₹426.15 | ₹69,381,481,500.00 | ₹253,775.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹753.90 | ₹68,329,440,018.00 | ₹548,769.00 |
| Strides Pharma Science Limited | STAR | ₹681.05 | ₹62,767,406,835.00 | ₹639,460.00 |
| Innova Captab Limited | INNOVACAP | ₹910.95 | ₹52,129,049,984.00 | ₹78,436.00 |
| Hikal Limited | HIKAL | ₹416.75 | ₹51,385,691,750.00 | ₹273,356.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹154.99 | ₹50,297,664,780.00 | ₹933,378.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹640.35 | ₹45,084,354,030.00 | ₹43,561.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹843.50 | ₹42,781,560,850.00 | ₹107,819.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,333.40 | ₹38,592,102,600.00 | ₹15,218.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹384.50 | ₹38,556,891,000.00 | ₹372,674.00 |
| Sequent Scientific Limited | SEQUENT | ₹154.04 | ₹38,556,520,080.00 | ₹1,239,540.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹62.22 | ₹34,093,697,880.00 | ₹39,557,174.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹365.85 | ₹33,391,129,500.00 | ₹235,772.00 |
| Suven Life Sciences Limited | SUVEN | ₹141.20 | ₹30,792,048,800.00 | ₹1,492,336.00 |
| Alembic Limited | ALEMBICLTD | ₹106.25 | ₹27,283,087,394.00 | ₹492,387.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹534.15 | ₹25,667,509,950.00 | ₹126,098.00 |
Key Executives
Senior General Manager of HR & Admin
Mr. Sudhakar Shetty
Gender: male
Year Born:
Company Secretary & Compliance Officer
Mr. Jeevan Bhargav Mondkar
Gender: male
Year Born:
Head of Business Development & Direct Procurement
Mr. Jasmin Mehta
Gender: male
Year Born:
MD & Director
Mr. Narendra Jagannath Salvi
Gender: male
Year Born: 1964
Head of API Export Regulated and R&D Management
Mr. Sachin Patil
Gender: male
Year Born:
President of R&D
Dr. B. S. Patravale
Gender: Not Specified
Year Born:
Head of Operations & Manufacturing, CDMO & CMO
Mr. G.M. Naidu
Gender: male
Year Born:
Chief Financial Officer
Mr. Piyush P. Lakhani
Gender: male
Year Born:
Vice Chairperson & MD
Ms. Hetal Gogri Gala
Gender: female
Year Born: 1975
FAQs about Aarti Pharmalabs Limited
Who is the CEO of the company?
The CEO is Ms. Hetal Gogri Gala.
What is the current market price of the stock?
The current price is ₹753.90.
What is the 52-week price range?
The range is ₹487.85-837.25.
What is the market capitalization of the company?
The market capitalization is ₹6,832.94 crores.
What is the dividend yield?
The dividend yield is 0.46%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 27.42.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Aarti Pharmalabs Limited (ISIN: INE0LRU01027) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹6,832.94 crores and an average daily volume of 924,090 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹3.5.